
Number of publications published per year by Ikejima, Kenichi. (Source : PubMed)

Distribution of publications types for Ikejima, Kenichi. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy.
J. Gastroenterol.
2010;45;2
Synthetic triglyceride containing an arachidonic acid branch (8A8) prevents lipopolysaccharide-induced liver injury.
Life Sci.
2009;85;17-18
Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-A(y) mice.
Hepatology
2009;49;5

Hepatic sinusoidal cells in health and disease: update from the 14th International Symposium.
Liver Int.
2009;29;4

The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation.
J. Gastroenterol.
2009;44;8

Translocation of iron from lysosomes into mitochondria is a key event during oxidative stress-induced hepatocellular injury.
Hepatology
2008;48;5
Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease.
Proc. Natl. Acad. Sci. U.S.A.
2008;105;31
[Anti-viral therapy of type C chronic hepatitis. 2. Progression of type C chronic hepatitis and resistance to treatment. 2) Participation of host factors]
Nippon Naika Gakkai Zasshi
2008;97;1

Liver diseases and metabolic syndrome.
J. Gastroenterol.
2008;43;7
Role of adipocytokines in hepatic fibrogenesis.
J. Gastroenterol. Hepatol.
2007;22 Suppl 1
[ See timeline ] [ See all publications ]
means that Ikejima, Kenichi has 22 papers cited a least 22 times - methodology
Department of Gastroenterology, Juntendo University, School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.